OSK vs VRTX · P/E 15, rev $10.42B vs P/E 30, rev $3.33B
Oshkosh Corporation (OSK) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Oshkosh Corporation (OSK) is a farm & heavy construction machinery company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported OSK revenue for 2025-12-31 was $10.42B. Net income was $647.0M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. OSK currently screens at market cap $8.59B and trailing P/E 15.2.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
OSK currently screens at market cap $8.59B and trailing P/E 15.2. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the OSK and VRTX stock pages for the full models.
Not investment advice.